Analysis of Guided Therapeutics’ FDA Study Data Reveals Compelling Clinical Need for LuViva
December 11, 2025
Guided Therapeutics Receives $88,000 Payment as Third Installment of $700,000 Purchase Order with Chinese Distributor
November 19, 2025
Guided Therapeutics Inks Initial $200,000 Deal with New Distribution Partner Yuanshuo Medical Instruments Corporation
August 19, 2025
Guided Therapeutics Receives $70,000 — Its Second of Nine Payments Totaling $700,000 — from New Chinese Distribution Partner that Provides Products for 2 Million Annual Cervical Cancer Screenings
August 13, 2025
Guided Therapeutics Provides Update on Completion of US FDA Clinical Trial
July 2, 2025
Guided Therapeutics Makes Initial Shipment to New Chinese Distribution Partner Hangzhou Dongye Medical Technology, Ltd.
June 10, 2025
Guided Therapeutics Receives $700,000 Purchase Order and Initial Payment from New Chinese Distributor
May 27, 2025
Guided Therapeutics Receives $100,000 from SMI’s Investment Partners to Continue Commercialization Process of LuViva in China
